Anti-inflammatory therapeutics market to grow to $85.9 billion in 2017

The anti-inflammatory therapeutics market accounted for $32.3 billion in 2002 from its seven major indications. From 2002, the market grew at a rate of 7.6% to $57.8 billion in 2010, and is forecast to grow at a rate of 5.8% during the forecast period, to produce revenues of $85.9 billion in 2017, according to forecasts from business intelligence group GBI Research.

This decrease from 7.6% to 5.8% will be due to patent expiries of some biologics and small molecules; these patent expiries will make an entry point for generics in the market, and their negative impact will be reversed by strong pipeline molecules that are currently in various phases of clinical trials.

Anti-inflammatory market major part of global pharma Industry